Literature DB >> 24171101

Bone cell communication factors and Semaphorins.

Takako Negishi-Koga1, Hiroshi Takayanagi.   

Abstract

Bone tissue is continuously renewed throughout adult life by a process called 'remodeling', which involves a dynamic interplay among bone cells including osteoclasts, osteoblasts and osteocytes. For example, a tight coupling between bone resorption and formation is essential for the homeostasis of the skeletal system. Studies on the coupling mechanism in physiological and pathological settings have revealed that osteoclasts or osteoclastic bone resorption promote bone formation through the production of diverse coupling factors. The classical coupling factors are the molecules that promote bone formation after resorption, but there may be distinct mechanisms at work in various phases of bone remodeling. A recent study revealed that the Semaphorin 4D expressed by osteoclasts inhibits bone formation, which represents a mechanism by which coupling is dissociated. Furthermore, it has been demonstrated that osteoblastic expression of Semaphorin 3A exerts an osteoprotective effect by both suppressing bone resorption and increasing bone formation. Thus, recent advances have made it increasingly clear that bone remodeling is regulated by not only classical coupling factors, but also molecules that mediate cell-cell communication among bone cells. We propose that such factors be called bone cell communication factors, which control the delicate balance of the interaction of bone cells so as to maintain bone homeostasis.

Entities:  

Year:  2012        PMID: 24171101      PMCID: PMC3810552          DOI: 10.1038/bonekey.2012.183

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN: 2047-6396


  55 in total

1.  Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion.

Authors:  Kristen E Govoni; Jon E Wergedal; Lore Florin; Peter Angel; David J Baylink; Subburaman Mohan
Journal:  Endocrinology       Date:  2007-08-23       Impact factor: 4.736

Review 2.  Regulation of bone remodeling by the central and peripheral nervous system.

Authors:  Florent Elefteriou
Journal:  Arch Biochem Biophys       Date:  2008-03-23       Impact factor: 4.013

3.  Regulation of osteoblastogenesis and bone mass by Wnt10b.

Authors:  Christina N Bennett; Kenneth A Longo; Wendy S Wright; Larry J Suva; Timothy F Lane; Kurt D Hankenson; Ormond A MacDougald
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

Review 4.  Disorders of bone remodeling.

Authors:  Xu Feng; Jay M McDonald
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

5.  Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis.

Authors:  Noriko Takegahara; Hyota Takamatsu; Toshihiko Toyofuku; Tohru Tsujimura; Tatsusada Okuno; Kazunori Yukawa; Masayuki Mizui; Midori Yamamoto; Durbaka V R Prasad; Kazuhiro Suzuki; Masaru Ishii; Kenta Terai; Masayuki Moriya; Yuji Nakatsuji; Saburo Sakoda; Shintaro Sato; Shizuo Akira; Kiyoshi Takeda; Masanori Inui; Toshiyuki Takai; Masahito Ikawa; Masaru Okabe; Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Nat Cell Biol       Date:  2006-05-21       Impact factor: 28.824

6.  Expression and function of semaphorin 7A in bone cells.

Authors:  Guillaume Delorme; Frederic Saltel; Edith Bonnelye; Pierre Jurdic; Irma Machuca-Gayet
Journal:  Biol Cell       Date:  2005-07       Impact factor: 4.458

7.  Osteoprotection by semaphorin 3A.

Authors:  Mikihito Hayashi; Tomoki Nakashima; Masahiko Taniguchi; Tatsuhiko Kodama; Atsushi Kumanogoh; Hiroshi Takayanagi
Journal:  Nature       Date:  2012-05-03       Impact factor: 49.962

8.  Osteoclasts secrete the chemotactic cytokine mim-1.

Authors:  M L Falany; A M Thames; J M McDonald; H C Blair; M A McKenna; R E Moore; M K Young; J P Williams
Journal:  Biochem Biophys Res Commun       Date:  2001-02-16       Impact factor: 3.575

9.  BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway.

Authors:  Nobuhiro Kamiya; Ling Ye; Tatsuya Kobayashi; Yoshiyuki Mochida; Mitsuo Yamauchi; Henry M Kronenberg; Jian Q Feng; Yuji Mishina
Journal:  Development       Date:  2008-10-16       Impact factor: 6.868

10.  Semaphorin III is needed for normal patterning and growth of nerves, bones and heart.

Authors:  O Behar; J A Golden; H Mashimo; F J Schoen; M C Fishman
Journal:  Nature       Date:  1996-10-10       Impact factor: 49.962

View more
  27 in total

1.  Osteoimmunology in 2014: Two-faced immunology-from osteogenesis to bone resorption.

Authors:  Hiroshi Takayanagi
Journal:  Nat Rev Rheumatol       Date:  2015-01-06       Impact factor: 20.543

Review 2.  Coupling factors involved in preserving bone balance.

Authors:  Beom-Jun Kim; Jung-Min Koh
Journal:  Cell Mol Life Sci       Date:  2018-12-04       Impact factor: 9.261

Review 3.  Semaphorins and plexins as therapeutic targets.

Authors:  Thomas Worzfeld; Stefan Offermanns
Journal:  Nat Rev Drug Discov       Date:  2014-08       Impact factor: 84.694

Review 4.  Molecular and cellular basis of bone resorption.

Authors:  Reinhard Gruber
Journal:  Wien Med Wochenschr       Date:  2014-09-16

5.  Osteoclast-secreted SLIT3 coordinates bone resorption and formation.

Authors:  Beom-Jun Kim; Young-Sun Lee; Sun-Young Lee; Wook-Young Baek; Young Jin Choi; Sung Ah Moon; Seung Hun Lee; Jung-Eun Kim; Eun-Ju Chang; Eun-Young Kim; Jin Yoon; Seung-Whan Kim; Sung Ho Ryu; Sun-Kyeong Lee; Joseph A Lorenzo; Seong Hee Ahn; Hyeonmok Kim; Ki-Up Lee; Ghi Su Kim; Jung-Min Koh
Journal:  J Clin Invest       Date:  2018-03-05       Impact factor: 14.808

6.  Ubiquitin E3 Ligase LNX2 is Critical for Osteoclastogenesis In Vitro by Regulating M-CSF/RANKL Signaling and Notch2.

Authors:  Jian Zhou; Toshifumi Fujiwara; Shiqiao Ye; Xiaolin Li; Haibo Zhao
Journal:  Calcif Tissue Int       Date:  2015-02-25       Impact factor: 4.333

7.  Adenosine A2A receptor (A2AR) stimulation modulates expression of semaphorins 4D and 3A, regulators of bone homeostasis.

Authors:  Aránzazu Mediero; Tuere Wilder; Lopa Shah; Bruce N Cronstein
Journal:  FASEB J       Date:  2018-02-02       Impact factor: 5.191

Review 8.  Emerging role of semaphorin-3A in autoimmune diseases.

Authors:  Li-Na Liu; Xiao-Mei Li; Dong-Qing Ye; Hai-Feng Pan
Journal:  Inflammopharmacology       Date:  2018-04-25       Impact factor: 4.473

9.  Myeloid-derived growth factor (MYDGF) protects bone mass through inhibiting osteoclastogenesis and promoting osteoblast differentiation.

Authors:  Xiaoli Xu; Yixiang Li; Lingfeng Shi; Kaiyue He; Ying Sun; Yan Ding; Biying Meng; Jiajia Zhang; Lin Xiang; Jing Dong; Min Liu; Junxia Zhang; Lingwei Xiang; Guangda Xiang
Journal:  EMBO Rep       Date:  2022-01-24       Impact factor: 8.807

10.  Clinical and radiographic findings without the use of bone substitute materials in extraction sockets and delayed implant placement- A case series.

Authors:  Lanka Mahesh; Jose Luis Calvo Guirado; Sagrika Shukla; Varun Raj Kumar; Yuvika Raj Kumar
Journal:  J Oral Biol Craniofac Res       Date:  2020-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.